| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
3.35 0.05 (0.02%) |
11-14 14:30 |
|
Open: |
3.16 |
Pre close: |
3.3 |
Target:
|
4.25
|
|
High: |
3.49 |
Low: |
3.14 |
Resistance:
|
3.64
4.20
|
|
Volume: |
141,009 |
Market Cap: |
290M |
Support:
|
2.73
2.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.39
 |
MACD |
MACD(12,26):
|
-0.21  |
|
MA(20): |
3.32 |
Signal(12,26,9): |
-0.30 |
|
MA(100): |
5.85 |
Stochastic Oscillator |
%K(14,3):
|
42.45 |
|
MA(250): |
5.23 |
%D(3): |
43.37 |
|
Average Volume(K) |
3-Month: |
34526
|
52-Week |
High:
|
8.89 |
|
10-Days: |
23877 |
Low: |
2.47 |
|
RSI |
RSI(14):
|
45.21 |
Change(%): |
38.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.230 |
Return on Equity (ttm) |
-32.0 |
Shares Out. (M) |
86.59 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-28.8 |
Shares Float (M) |
84.50 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.60 |
|
Forward EPS |
-0.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.720 |
EBITDA (p.s.) |
-0.018 |
P/E |
-14.87 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.92 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.71 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.87 |
P/CF |
-25.29 |
|
|
|
|
|
|
